title: Primary hepatosplenic CD5-positive diffuse large B-cell lymphoma: a case report with literature review.
abstract: De novo CD5-positive diffuse large B-cell lymphoma (CD5(+) DLBCL) accounts for approximately 10% of DLBCL, and is usually associated with aggressive clinical course. We report a case of CD5(+) DLBCL with primary involvement of the spleen and liver, and no distinct mass lesions or lymphadenopathy. The patient had stage IV disease with bone marrow involvement by lymphoma. The lymphoma cells showed characteristic portal and intrasinusoidal pattern of infiltrate in the liver. The literature was reviewed and the clinicopathologic features of 7 similar reported cases were summarized. All cases share the common features of hepatosplenomegaly without mass lesions, exclusive red pulp infiltrate with a diffuse and cordal pattern in the spleen, portal and intrasinusoidal pattern of infiltrate in the liver, and stage IV disease with poor response to conventional chemotherapy. This may represent a distinct subgroup of CD5(+) DLBCL and the diagnosis is important for prompt clinical treatment.
authors: Hematopathology and Laboratory Medicine, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.
authors: Xiaohui
authors: X
authors: Zhang
authors: Manhua
authors: M
authors: Sun
authors: Ling
authors: L
authors: Zhang
authors: Haipeng
authors: H
authors: Shao
mesh_terms: D000369:Aged, 80 and over; D018956:CD5 Antigens / Q000096:biosynthesis*; D006801:Humans; D008113:Liver Neoplasms / Q000378:metabolism / Q000473:pathology*; D016403:Lymphoma, Large B-Cell, Diffuse / Q000378:metabolism / Q000473:pathology*; D008297:Male; D013160:Splenic Neoplasms / Q000378:metabolism / Q000473:pathology*
chemical_list: D018956:CD5 Antigens
keywords: CD5; diffuse large B-cell lymphoma; hepatosplenomegaly
references: Am J Pathol. 1995 Jul;147(1):207-16
references: 7541611
references: J Korean Med Sci. 2004 Dec;19(6):815-9
references: 15608391
references: Virchows Arch. 2008 Nov;453(5):501-9
references: 18818942
references: Blood. 2011 Jun 30;117(26):7070-8
references: 21536860
references: Haematologica. 2008 Aug;93(8):1195-202
references: 18556402
references: Br J Haematol. 1999 Jun;105(4):1133-9
references: 10554834
references: Ann Oncol. 2010 Oct;21(10):2069-2074
references: 20231297
references: Acta Haematol. 1993;89(1):46-9
references: 8480487
references: Leuk Lymphoma. 2010 Jan;51(1):161-3
references: 19863175
references: Am J Clin Pathol. 2000 Oct;114(4):523-33
references: 11026098
references: Ann Oncol. 2008 Nov;19(11):1921-6
references: 18573805
references: Cancer. 1988 Aug 1;62(3):593-600
references: 3292036
references: Mod Pathol. 1997 Jan;10(1):18-32
references: 9021723
references: Hematol Oncol. 2010 Mar;28(1):27-32
references: 19358143
references: Blood. 2002 Feb 1;99(3):815-21
references: 11806981